Skip to main content

Table 2 Summary of case history findings (N = 50)

From: Feasibility and first results of a prospective cohort study to investigate cisplatin-associated ototoxicity amongst cancer patients in South Africa

Patient Complaints

Baseline

Mid-cycle

1-month post-treatment

p-value

Repeated Ear infections

2 (4)

2 (4)

2 (4)

0.988

 Bilateral

0

0

0

 Left ear only

1 (50)

1 (50)

1 (50)

 Right

1 (50)

1 (50)

1 (50)

Reduced hearing

7 (14)

8 (16)

11 (22)

0.36

 Bilateral

4 (57.1)

5 (62.5)

5 (45.4)

 Left ear only

1 (14.3)

1 (12.5)

3 (27.3)

 Right ear only

2 (28.6)

2 (25)

3 (27.3)

Otalgia

3 (6)

8 (16)

5 (10)

0.52

Tinnitus

21 (42)

26 (52)

17 (34)

0.42

 Bilateral

10 (47.6)

14 (53.9)

11 (64.7)

 Left ear only

8 (38.1)

7 (26.9)

1 (5.9)

 Right ear only

1 (4.8)

3 (11.5)

4 (23.5)

 Head

2 (9.5)

2 (7.7)

1 (5.9)

  1. *Cochran-Armitage test for a linear trend in proportions